BATM Advanced Communications Ltd - Israel-based networking and medical technology company - says it has developed a new test for the rapid and comprehensive diagnosis of tuberculosis. Test takes two hours instead of several days with current methods. Clinical trials to start in second half of this year, fully funded by UN's Stop TB Partnership. Expects sales to begin next year.
Current stock price: 98.40 pence
Year-to-date change: up 5.8%
By Ivan Edwards; ivanedwards@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.


(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:


(Alliance News) - BATM Advanced Communications Ltd on Monday reported a plunge in full-year profit and revenue as demand dropped for Covid-19 products...


BATM Advanced Communications Ltd - Hod Hasharon, Israel-based networking and medical technology company - Wins a government cyber security order, wort...


(Sharecast News) - BATM Advanced Communications said on Monday that it has received a "substantial" government cyber security order with a value of $2...


(Alliance News) - BATM Advanced Communications Ltd on Thursday announced a multi-year contract with CityFibre Holdings Ltd, and expects multi-million ...


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:


(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: